News » DM Zone news, England, Wales » Jan Cat M adjustments published
December 23rd 2024
DHSC has published the quarter 4 (January) Category M adjustment. This aims to achieve a reduction in medicine margin of £17.9 million per quarter.
In this adjustment, there are six additions and eight deletions.
The additions are:
|
Drug |
Pack size |
Price (£) |
|
Gliclazide 30mg modified-release tablets |
28 |
1.67 |
|
Progesterone micronised 100mg capsules |
30 |
4.48 |
|
Rivaroxaban 2.5mg tablets |
56 |
3.19 |
|
Rivaroxaban 10mg tablets |
30 |
4.09 |
|
Clarithromycin 250mg/5ml oral suspension |
20 |
10.22 |
|
Sulfasalazine 500mg gastro-resistant tablets |
112 |
26.97 |
DDA members can view further analysis of the price reductions and a full spreadsheet showing the prices, with history, and sorted by price order, change and % price change.
Visit the online Category M library
